+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), Technology, Application, and Region with Growth Forecasts, 2025-2030- Product Image
Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), Technology, Application, and Region with Growth Forecasts, 2025-2030- Product Image
New

Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), Technology, Application, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 130 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 4613457
Description Jump to:
The Radiation Oncology Market was valued at USD 10.56 billion in 2024, and is projected to reach USD 21.19 billion by 2030, rising at a CAGR of 11.17%. The growth of the market is attributed to the global rise in cancer burden, the growing geriatric population, and supportive reimbursement programs undertaken by the government and private organizations. Furthermore, the increasing technological innovation and advancement in radiotherapy offer lucrative opportunities for market growth.

The world is witnessing an increasing prevalence of cancer cases which is the key factor driving the radiation oncology market growth. For instance, according to Globocan, in 2020, more than 20.0 million people were diagnosed with cancer, and 10.0 million died of cancer. Moreover, the aging population is at high risk of cancer due to a weak immune system and comorbid conditions; thereby, the rising geriatric population further fuels market growth. For instance, in 2020, according to WHO estimates, the global geriatric population was approximately 1.0 billion and is expected to reach 2.1 billion by 2050.

Extensive research activities for the development of novel radiotherapy techniques and multidisciplinary therapeutic approaches are expected to lead to an increased survival rate and a more favorable prognosis of cancer. For instance, in December 2022, Elekta Unity demonstrated MR-Linac use for pancreatic tumors, where the first-ever patient was treated with new advanced radiotherapy motion management.

Similarly, in June 2020, Isoray signed a research agreement with the University of Cincinnati Physicians Company to study neck and head cancer treatment. The companies will evaluate the efficacy of Keytruda along with Cesium-131 post-surgical resection. Using such medical isotopes for cancer treatment may boost the research in developing a new target-specific radiation therapy system by understanding disease complexity & patients' need, thereby widening the opportunity in the market.

Furthermore, supportive reimbursement and regulatory policies for radiation therapy are also expected to drive the radiation oncology market growth. For instance, in July 2021, the Centers for Medicare and Medicaid Services (CMS) developed a new Radiation Oncology Payment Model (RO-APM) for the diagnosis of cancer and radiotherapy services. It enhances the quality of care of the patients and reduces the annual Medicare expenditure.

Radiation Oncology Market Report Highlights

  • The external beam radiation therapy (EBRT) market, which includes linear accelerators (Linac), and compact advanced radiotherapy systems, dominated the overall market with the largest revenue share in 2024 due to increased adoption in the treatment of various types of cancers
  • The IMRT segment held the largest revenue share of 24.06% in 2024, attributed to the substantial demand for treatment and increased availability of technologically advanced intensity-modulated radiotherapy (IMRT) in countries with unmet treatment needs.
  • The EBRT segment for prostate cancer held the largest revenue share of 58.65% in 2024 and is anticipated to maintain its dominance over the forecast period
  • The market for IBRT is anticipated to witness significant growth over the forecast period due to the growing prevalence of cancer in developing countries and increased product penetration
  • North America radiation oncology industry dominated globally in terms of revenue share of 47.16% in 2024, owing to the favorable government initiatives and availability of technologically advanced radiotherapy equipment

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Technology
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Technology outlook
2.2.3. Applicationoutlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Radiation Oncology Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Rising adoption of radiotherapy
3.4.2. Technological advancements in radiotherapy
3.4.3. Rising prevalence of cancer
3.4.4. Increase in healthcare expenditure
3.4.5. Increasing application of radiopharmaceuticalsg
3.5. Market Restraint Analysis
3.5.1. Lack Of Skilled Radiotherapy Professionals
3.5.2. Inadequate Radiation Infrastructure
3.5.3. Adverse Effects Of RadiotherapyType Analysis Tools
3.5.4. Porter’s Five Forces Analysis
3.5.5. PESTEL Analysis
Chapter 4. Radiation Oncology Market: Type Estimates & Trend Analysis
4.1. Radiation Oncology Market: Type Movement Analysis
4.2. Radiation Oncology Market Estimates and Forecast, by Type
4.3. External Beam Radiation Therapy
4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.2. Linear Accelerators (Linac)
4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.3. Compact advanced radiotherapy systems
4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.3.2. Cyberknife
4.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.3.3. Gamma Knife
4.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.3.4. Tomotherapy
4.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.4. Proton Therapy
4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.4.2. Cyclotron
4.3.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.4.3. Synchrotron
4.3.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4. Internal Beam Radiation Therapy
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Brachytherapy
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Seeds
4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Applicators and After loaders
4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.4. Electronic Brachytherapy
4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Systemic Beam Radiation Therapy
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Others
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Radiation Oncology Market: Technology Estimates & Trend Analysis
5.1. Radiation Oncology Market: Technology Movement Analysis
5.2. Radiation Oncology Market Estimates and Forecast, by Technology
5.3. External Beam Radiation Therapy
5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.2. Image-Guided Radiotherapy (IGRT)
5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3. Intensity Modulated Radiotherapy (IMRT)
5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.4. Stereotactic Technology
5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.5. Proton Beam Therapy
5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.6. 3D Conformal Radiotherapy (3D CRT)
5.3.7. Volumetric Modulated Arc Therapy (VMAT)
5.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4. Brachytherapy
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Low-Dose Rate Brachytherapy
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. High-Dose Rate Brachytherapy
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Radiation Oncology Market: Application Estimates & Trend Analysis
6.1. Radiation Oncology Market: Application Movement Analysis
6.2. Radiation Oncology Market Estimates and Forecast, by End Use
6.3. External Beam Radiation Therapy
6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Prostate Cancer
6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.3. Breast Cancer
6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.4. Lung Cancer
6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.5. Head and Neck Cancer
6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.6. Colorectal Cancer
6.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.7. Others
6.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4. Internal Beam Radiation Therapy
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Prostate Cancer
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Breast Cancer
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Lung Cancer
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Head and Neck Cancer
6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. Colorectal Cancer
6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.7. Others
6.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Radiation Oncology Market: Regional Estimates & Trend Analysis
7.1. Radiation Oncology Market Share By Region, 2024 & 2030
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Regional Market Dashboard
7.4. Global Regional Market Snapshot
7.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.6. North America
7.6.1. North America Radiation Oncology Market, 2018-2030 (USD Million)
7.6.2. U.S.
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. U.S. Radiation Oncology Market, 2018-2030 (USD Million)
7.6.3. Canada
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Canada Radiation Oncology Market, 2018-2030 (USD Million)
7.6.4. Mexico
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Mexico Radiation Oncology Market, 2018-2030 (USD Million)
7.7. Europe
7.7.1. Europe Radiation Oncology Market, 2018-2030 (USD Million)
7.7.2. UK
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. UK Radiation Oncology Market, 2018-2030 (USD Million)
7.7.3. Germany
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Germany Radiation Oncology Market, 2018-2030 (USD Million)
7.7.4. France
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. France Radiation Oncology Market, 2018-2030 (USD Million)
7.7.5. Italy
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Italy Radiation Oncology Market, 2018-2030 (USD Million)
7.7.6. Spain
7.7.6.1. Key Country Dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory Framework
7.7.6.4. Spain Radiation Oncology Market, 2018-2030 (USD Million)
7.7.7. Denmark
7.7.7.1. Key Country Dynamics
7.7.7.2. Competitive Scenario
7.7.7.3. Regulatory Framework
7.7.7.4. Denmark Radiation Oncology Market, 2018-2030 (USD Million)
7.7.8. Sweden
7.7.8.1. Key Country Dynamics
7.7.8.2. Competitive Scenario
7.7.8.3. Regulatory Framework
7.7.8.4. Sweden Radiation Oncology Market, 2018-2030 (USD Million)
7.7.9. Norway
7.7.9.1. Key Country Dynamics
7.7.9.2. Competitive Scenario
7.7.9.3. Regulatory Framework
7.7.9.4. Norway Radiation Oncology Market, 2018-2030 (USD Million)
7.8. Asia Pacific
7.8.1. Asia Pacific Radiation Oncology Market, 2018-2030 (USD Million)
7.8.2. Japan
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Japan Radiation Oncology Market, 2018-2030 (USD Million)
7.8.3. China
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. China Radiation Oncology Market, 2018-2030 (USD Million)
7.8.4. India
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. India Radiation Oncology Market, 2018-2030 (USD Million)
7.8.5. Australia
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Australia Radiation Oncology Market, 2018-2030 (USD Million)
7.8.6. Thailand
7.8.6.1. Key Country Dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Regulatory Framework
7.8.6.4. Thailand Radiation Oncology Market, 2018-2030 (USD Million)
7.8.7. South Korea
7.8.7.1. Key Country Dynamics
7.8.7.2. Competitive Scenario
7.8.7.3. Regulatory Framework
7.8.7.4. South Korea Radiation Oncology Market, 2018-2030 (USD Million)
7.9. Latin America
7.9.1. Latin America Radiation Oncology Market, 2018-2030 (USD Million)
7.9.2. Brazil
7.9.2.1. Key Country Dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory Framework
7.9.2.4. Brazil Radiation Oncology Market, 2018-2030 (USD Million)
7.9.3. Argentina
7.9.3.1. Key Country Dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory Framework
7.9.3.4. Argentina Radiation Oncology Market, 2018-2030 (USD Million)
7.10. MEA
7.10.1. MEA Radiation Oncology Market, 2018-2030 (USD Million)
7.10.2. South Africa
7.10.2.1. Key Country Dynamics
7.10.2.2. Competitive Scenario
7.10.2.3. Regulatory Framework
7.10.2.4. South Africa Radiation Oncology Market, 2018-2030 (USD Million)
7.10.3. Saudi Arabia
7.10.3.1. Key Country Dynamics
7.10.3.2. Competitive Scenario
7.10.3.3. Regulatory Framework
7.10.3.4. Saudi Arabia Radiation Oncology Market, 2018-2030 (USD Million)
7.10.4. UAE
7.10.4.1. Key Country Dynamics
7.10.4.2. Competitive Scenario
7.10.4.3. Regulatory Framework
7.10.4.4. UAE Radiation Oncology Market, 2018-2030 (USD Million)
7.10.5. Kuwait
7.10.5.1. Key Country Dynamics
7.10.5.2. Competitive Scenario
7.10.5.3. Regulatory Framework
7.10.5.4. Kuwait Radiation Oncology Market, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Strategy Mapping
8.4. Company Market Share Analysis, 2024
8.5. Company Profiles
8.5.1. Varian Medical Systems, Inc.
8.5.1.1. Overview
8.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Elekta AB
8.5.2.1. Overview
8.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Accuray Incorporated
8.5.3.1. Overview
8.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. IBA Radiopharma Solutions
8.5.4.1. Overview
8.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. BD (Becton, Dickinson and Company)
8.5.5.1. Overview
8.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Isoray Inc.
8.5.6.1. Overview
8.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Mevion Medical Systems
8.5.7.1. Overview
8.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Nordion, Inc.
8.5.8.1. Overview
8.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. NTP Radioisotopes SOC Ltd.
8.5.9.1. Overview
8.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Curium
8.5.10.1. Overview
8.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
8.5.11. ViewRay Technologies, Inc.
8.5.11.1. Overview
8.5.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 3 Global Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 4 Global Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 5 Global Radiation Oncology Market, by Region, 2018-2030 (USD Million)
Table 6 North America Radiation Oncology Market, by Country, 2018-2030 (USD Million)
Table 7 North America Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 8 North America Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 9 North America Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 10 U.S. Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 11 U.S. Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 12 U.S. Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 13 Canada Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 14 Canada Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 15 Canada Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 16 Europe Radiation Oncology Market, by Country, 2018-2030 (USD Million)
Table 17 Europe Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 18 Europe America Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 19 Europe America Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 20 UK Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 21 UK Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 22 UK Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 23 Germany Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 24 Germany Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 25 Germany Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 26 France Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 27 France Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 28 France Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 29 Italy Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 30 Italy Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 31 Italy Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 32 Spain Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 33 Spain Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 34 Spain Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 35 Denmark Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 36 Denmark Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 37 Denmark Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 38 Denmark Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 39 Sweden Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 40 Sweden Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 41 Sweden Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 42 Norway Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 43 Norway Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 44 Norway Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 45 Asia Pacific Radiation Oncology Market, by Country, 2018-2030 (USD Million)
Table 46 Asia Pacific Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 47 Asia Pacific Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 48 Asia Pacific Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 49 Japan Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 50 Japan Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 51 Japan Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 52 China Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 53 China Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 54 China Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 55 India Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 56 India Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 57 India Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 58 Australia Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 59 Australia Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 60 Australia Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 61 Thailand Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 62 Thailand Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 63 Thailand Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 64 South Korea Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 65 South Korea Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 66 South Korea Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 67 Latin America Radiation Oncology Market, by Country, 2018-2030 (USD Million)
Table 68 Latin America Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 69 Latin America Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 70 Latin America Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 71 Brazil Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 72 Brazil Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 73 Brazil Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 74 Mexico Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 75 Mexico Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 76 Mexico Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 77 Argentina Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 78 Argentina Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 79 Argentina Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 80 Middle East & Africa Radiation Oncology Market, by Country, 2018-2030 (USD Million)
Table 81 Middle East & Africa Radiation Oncology Market, by type, 2018-2030 (USD Million)
Table 82 Middle East & Africa Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 83 Middle East & Africa Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 84 South Africa Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 85 South Africa Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 86 South Africa Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 87 Saudi Arabia Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 88 Saudi Arabia Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 89 audi Arabia Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 90 UAE Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 91 UAE Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 92 UAE Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
Table 93 Kuwait Radiation Oncology Market, by Type, 2018-2030 (USD Million)
Table 94 Kuwait Radiation Oncology Market, by Technology, 2018-2030 (USD Million)
Table 95 Kuwait Radiation Oncology Market, by End-use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing & forecasting
Figure 6 Market formulation & validation
Figure 7 Radiation Oncology Market segmentation
Figure 8 Market snapshot, 2024
Figure 9 Market trends & outlook
Figure 10 Market driver relevance analysis (current & future impact)
Figure 11 Market restraint relevance analysis (current & future impact)
Figure 12 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 13 Porter’s five forces analysis
Figure 14 Radiation oncology market: Type movement analysis
Figure 15 Radiation oncology market: Type outlook and key takeaways
Figure 16 External Beam Radiation Therapy market estimates and forecast, 2018-2030
Figure 17 Linear Accelerators (Linac) market estimates and forecast, 2018-2030
Figure 18 Compact advanced radiotherapy systems market estimates and forecast, 2018-2030
Figure 19 Cyberknife market estimates and forecast, 2018-2030
Figure 20 Gamma Knife market estimates and forecast, 2018-2030
Figure 21 Tomotherapy market estimates and forecast, 2018-2030
Figure 22 Proton Therapy market estimates and forecast, 2018-2030
Figure 23 Cyclotron market estimates and forecast, 2018-2030
Figure 24 Synchrotron market estimates and forecast, 2018-2030
Figure 25 Internal Beam Radiation Therapy market estimates and forecast, 2018-2030
Figure 26 Brachytherapy market estimates and forecast, 2018-2030
Figure 27 Seeds market estimates and forecast, 2018-2030
Figure 28 Applicators and After loaders market estimates and forecast, 2018-2030
Figure 29 Electronic Brachytherapy market estimates and forecast, 2018-2030
Figure 30 Systemic Beam Radiation Therapy market estimates and forecast, 2018-2030
Figure 31 Others market estimates and forecast, 2018-2030
Figure 32 Radiation oncology market: Technology movement analysis
Figure 33 Radiation oncology market: Technology outlook and key takeaways
Figure 34 External Beam Radiation Therapy market estimates and forecast, 2018-2030
Figure 35 Image-Guided Radiotherapy (IGRT) market estimates and forecast, 2018-2030
Figure 36 Intensity Modulated Radiotherapy (IMRT) market estimates and forecast, 2018-2030
Figure 37 Stereotactic Technology market estimates and forecast, 2018-2030
Figure 38 Proton Beam Therapy market estimates and forecast, 2018-2030
Figure 39 3D Conformal Radiotherapy (3D CRT) market estimates and forecast, 2018-2030
Figure 40 Volumetric Modulated Arc Therapy (VMAT) market estimates and forecast, 2018-2030
Figure 41 Brachytherapy market estimates and forecast, 2018-2030
Figure 42 Low-Dose Rate Brachytherapy market estimates and forecast, 2018-2030
Figure 43 High-Dose Rate Brachytherapy market estimates and forecast, 2018-2030
Figure 44 Radiation oncology market: Application movement analysis
Figure 45 Radiation oncology market: Application outlook and key takeaways
Figure 46 External Beam Radiation Therapy market estimates and forecast, 2018-2030
Figure 47 Prostate Cancer market estimates and forecast, 2018-2030
Figure 48 Breast Cancer market estimates and forecast, 2018-2030
Figure 49 Lung Cancer market estimates and forecast, 2018-2030
Figure 50 Head and Neck Cancer market estimates and forecast, 2018-2030
Figure 51 Colorectal Cancer market estimates and forecast, 2018-2030
Figure 52 Others market estimates and forecast, 2018-2030
Figure 53 Internal Beam Radiation Therapy market estimates and forecast, 2018-2030
Figure 54 Prostate Cancer market estimates and forecast, 2018-2030
Figure 55 Gynecological Cancer market estimates and forecast, 2018-2030
Figure 56 Cervical Cancer market estimates and forecast, 2018-2030
Figure 57 Breast Cancer market estimates and forecast, 2018-2030
Figure 58 Penile Cancer market estimates and forecast, 2018-2030
Figure 59 Others market estimates and forecast, 2018-2030
Figure 60 Regional outlook, 2024 & 2030
Figure 61 Global Radiation Oncology Market: Region movement analysis
Figure 62 North America Radiation Oncology Market, 2018-2030 (USD Million)
Figure 63 U.S. Radiation Oncology Market, 2018-2030 (USD Million)
Figure 64 Canada Radiation Oncology Market, 2018-2030 (USD Million)
Figure 65 Mexico Radiation Oncology Market, 2018-2030 (USD Million)
Figure 66 Europe Radiation Oncology Market, 2018-2030 (USD Million)
Figure 67 Germany Radiation Oncology Market, 2018-2030 (USD Million)
Figure 68 UK Radiation Oncology Market, 2018-2030 (USD Million)
Figure 69 France Radiation Oncology Market, 2018-2030 (USD Million)
Figure 70 Italy Radiation Oncology Market, 2018-2030 (USD Million)
Figure 71 Spain Radiation Oncology Market, 2018-2030 (USD Million)
Figure 72 Denmark Radiation Oncology Market, 2018-2030 (USD Million)
Figure 73 Sweden Radiation Oncology Market, 2018-2030 (USD Million)
Figure 74 Norway Radiation Oncology Market, 2018-2030 (USD Million)
Figure 75 Asia Pacific Radiation Oncology Market, 2018-2030 (USD Million)
Figure 76 Japan Radiation Oncology Market, 2018-2030 (USD Million)
Figure 77 China Radiation Oncology Market, 2018-2030 (USD Million)
Figure 78 India Radiation Oncology Market, 2018-2030 (USD Million)
Figure 79 Australia Radiation Oncology Market, 2018-2030 (USD Million)
Figure 80 South Korea Radiation Oncology Market, 2018-2030 (USD Million)
Figure 81 Thailand Radiation Oncology Market, 2018-2030 (USD Million)
Figure 82 Latin America Radiation Oncology Market, 2018-2030 (USD Million)
Figure 83 Brazil Radiation Oncology Market, 2018-2030 (USD Million)
Figure 84 Argentina Radiation Oncology Market, 2018-2030 (USD Million)
Figure 85 Middle East and Africa Radiation Oncology Market, 2018-2030 (USD Million)
Figure 86 South Africa Radiation Oncology Market, 2018-2030 (USD Million)
Figure 87 Saudi Arabia Radiation Oncology Market, 2018-2030 (USD Million)
Figure 88 UAE Radiation Oncology Market, 2018-2030 (USD Million)
Figure 89 Kuwait Radiation Oncology Market, 2018-2030 (USD Million)

Companies Mentioned

The major companies featured in this Radiation Oncology market report include:
  • Varian Medical Systems, Inc.
  • Elekta AB
  • Accuray Incorporated
  • IBA Radiopharma Solutions
  • BD (Becton, Dickinson and Company)
  • Isoray Inc.
  • Mevion Medical Systems
  • Nordion, Inc.
  • NTP Radioisotopes SOC Ltd.
  • Curium
  • ViewRay Technologies, Inc.

Table Information

Report AttributeDetails
No. of Pages130
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 10.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 21.19 Billion
Compound Annual Growth Rate11.1%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Radiation Oncology Market by Technology, Application, End User, Component, Delivery Mode - Global Forecast to 2030 - Product Image

Radiation Oncology Market by Technology, Application, End User, Component, Delivery Mode - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
Radiotherapy/Radiation Oncology Devices - Market Insights, Competitive Landscape, and Market Forecast -2030 - Product Image

Radiotherapy/Radiation Oncology Devices - Market Insights, Competitive Landscape, and Market Forecast -2030

  • Report
  • 150 Pages
  • Global
From
Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2025-2033 - Product Image

Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Radiation Therapy Equipment - Global Strategic Business Report - Product Image

Radiation Therapy Equipment - Global Strategic Business Report

  • Report
  • 508 Pages
  • Global
From
Intraoperative Radiation Therapy Market by Application, Technology, End User - Global Forecast to 2030 - Product Image

Intraoperative Radiation Therapy Market by Application, Technology, End User - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.